On the public citation graph
Targeting Pd-L1 Combined with Paclitaxel Hampers Gastric Cancer Progression by Modulating Cell Proliferation, Apoptosis, and Migration
0 signed · 31 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jcp.28823openalex-extracted
The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration
inferredcites →https://doi.org/10.1007/s00262-004-0593-xopenalex-extracted
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
inferredcites →https://doi.org/10.1007/s13225-013-0228-7openalex-extracted
Getting to the bottom of Taxol biosynthesis by fungi
inferredcites →https://doi.org/10.1016/j.biopha.2021.111436openalex-extracted
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines
inferredcites →https://doi.org/10.1016/j.cis.2018.11.004openalex-extracted
Basic principles of drug delivery systems – the case of paclitaxel
inferredcites →https://doi.org/10.1016/j.ejps.2018.10.021openalex-extracted
PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment
inferredcites →https://doi.org/10.1016/j.gene.2020.145376openalex-extracted
Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer
inferredcites →https://doi.org/10.1016/j.gene.2023.147803openalex-extracted
MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods
inferredcites →https://doi.org/10.1016/j.intimp.2021.107443openalex-extracted
PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression
inferredcites →https://doi.org/10.1016/j.lfs.2017.08.027openalex-extracted
RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
inferredcites →https://doi.org/10.1016/j.lfs.2020.117984openalex-extracted
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
inferredcites →https://doi.org/10.1016/j.yexcr.2023.113667openalex-extracted
Combination of B7H6-siRNA and temozolomide synergistically reduces stemness and migration properties of glioblastoma cancer cells
inferredcites →https://doi.org/10.1038/cgt.2014.61openalex-extracted
MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2
inferredcites →https://doi.org/10.1038/s41416-019-0697-xopenalex-extracted
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
inferredcites →https://doi.org/10.1038/s41598-022-15020-0openalex-extracted
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
inferredcites →https://doi.org/10.1134/s1062359022150109openalex-extracted
The Effects of siRNA-Mediated Gene Silencing of Alpha-7 Nicotinic Acetylcholine Receptors on Drug Resistance to Oxaliplatin in Colorectal Cancer Cells
inferredcites →https://doi.org/10.1155/2011/451694openalex-extracted
The PD‐1/PD‐L1 (B7‐H1) Pathway in Chronic Infection‐Induced Cytotoxic T Lymphocyte Exhaustion
inferredcites →https://doi.org/10.1159/000460504openalex-extracted
Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy
inferredcites →https://doi.org/10.1177/1010428317714626openalex-extracted
Progress in the treatment of advanced gastric cancer
inferredcites →https://doi.org/10.1177/20503121211034366openalex-extracted
New approaches and procedures for cancer treatment: Current perspectives
inferredcites →https://doi.org/10.3389/fimmu.2018.02374openalex-extracted
Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
inferredcites →https://doi.org/10.3389/fimmu.2020.568931openalex-extracted
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
inferredcites →https://doi.org/10.3390/cells10092366openalex-extracted
PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells
inferredcites →https://doi.org/10.3390/ijms222312783openalex-extracted
Downregulation of MMP-9 Enhances the Anti-Migratory Effect of Cyclophosphamide in MDA-MB-231 and MCF-7 Breast Cancer Cell Lines
inferredcites →https://doi.org/10.3390/ijms24076294openalex-extracted
Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma
inferredcites →https://doi.org/10.3390/nano7040077openalex-extracted
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
inferredcites →https://doi.org/10.3892/mmr.2020.11719openalex-extracted
miR‑576‑3p overexpression enhances cisplatin sensitivity of ovarian cancer cells by dysregulating PD‑L1 and cyclin D1
inferredcites →https://doi.org/10.4149/neo_2019_190202n106openalex-extracted
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells
inferredcites →https://doi.org/10.7150/thno.49717openalex-extracted
Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis
inferredcites →https://doi.org/10.3322/caac.21660openalex-snapshot
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.